Endometrial cancer isn’t talked about much as much as it should be. It’s the most common cancer of the female reproductive organs in the U.S. and more than 69,000 people in the U.S. are diagnosed with ...
A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...
Endometriosis, a prevalent gynecological condition, is characterized by the growth of endometrial-like tissues outside the ...
GSK PLC on Monday said the European Commission has expanded approval for its drug Jemperli, in combination with chemo ... Subscribe now to see this Premium News article from Alliance News ...
Endometrial cancer starts in the tissue that lines your uterus. If the cancer is platinum-resistant, platinum-based chemotherapy drugs will not work well to kill it or stop it from returning after ...
Jemperli (Dostarlimab): GlaxoSmithKline Jemperli (dostarlimab) is an anti-PD-1 monoclonal antibody developed by GlaxoSmithKline that has been approved for use in advanced or recurrent endometrial ...
20d
GlobalData on MSNGSK and University of Oxford partner for cancer vaccine researchGSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore the potential of cancer prevention through vaccination. The partnership, ...
Ear cancer is when abnormal cells in the ear start to grow and divide in an uncontrolled way. Most of these cancers start in the skin of the outer ear. Cancers that develop inside the ear, known as ...
Used to treat advanced or recurrent endometrial cancer, Jemperli Dostarlimab, presents an opportunity to enhance the immune response against cancer cells when combined with chemotherapy. Get Your Free ...
Used to treat advanced or recurrent endometrial cancer, Jemperli Dostarlimab, presents an opportunity to enhance the immune response against cancer cells when combined with chemotherapy.
GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer prevention through vaccination. The GSK-Oxford Cancer Immuno ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results